LRCX Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Net Income

Quarterly

Annual

Quarterly Cash Flow Statements

Quarterly

Annual

Unit: USD	2024-03-31	2023-12-24	2023-09-24	2023-06-25	2023-03-26	2022-12-25	2022-09-25	2022-06-26	2022-03-27	2021-12-26	2021-09-26	2021-06-27	2021-03-28	2020-12-27	2020-09-27	2020-06-28	2020-03-29	2019-12-29	2019-09-29	2019-06-30	2019-03-31	2018-12-23	2018-09-23	2018-06-24	2018-03-25	2017-12-24	2017-09-24	2017-06-25	2017-03-26	2016-12-25	2016-09-25	2016-06-26	2016-03-27	2015-12-27	2015-09-27	2015-06-28	2015-03-29	2014-12-28	2014-09-28	2014-06-29	2014-03-30	2013-12-29	2013-09-29	2013-06-30	2013-03-31	2012-12-23	2012-09-23	2012-06-24	2012-03-25	2011-12-25	2011-09-25	2011-06-26	2011-03-27	2010-12-26	2010-09-26	2009-09-27	2009-06-28	2009-03-29	2008-12-28	2008-09-28	2008-06-29	2008-03-30	2007-12-23	2007-09-23	2007-06-24	2007-03-25	2006-12-24	2006-09-24	2006-06-25	2006-03-26	2005-12-25	2005-09-25	2005-06-26	2005-03-27	2004-12-26	2004-09-26	2004-06-27	2004-03-28	2003-12-28	2003-09-28	2003-06-29

cash flows from operating activities:
net income	965,826,000	954,266,000	887,398,000	802,537,000	814,008,000	1,468,507,000	1,425,879,000	1,208,934,000	1,021,778,000	1,194,830,000	1,179,744,000	1,144,657,000	1,071,121,000	869,229,000	823,451,000	696,673,000	574,781,000	514,510,000	465,789,000	541,825,000	547,390,000	568,855,000	533,360,000	1,021,146,000	778,800,000	-9,955,000	590,690,000	526,424,000	574,713,000	332,791,000	263,835,000	258,939,000	143,451,000	222,980,000	288,679,000	131,271,000	206,285,000	176,940,000	141,081,000	233,395,000	164,396,000	148,992,000	85,506,000	85,707,000	18,996,000	6,408,000	2,768,000	18,069,000	45,604,000	33,212,000	71,838,000	125,928,000	182,240,000	221,856,000	193,724,000	16,797,000	-88,490,000	-198,359,000	-24,172,000	8,873,000	72,178,000	103,524,000	115,059,000	148,588,000	170,231,000	164,741,000	167,326,000	183,518,000	122,149,000	86,337,000	77,778,000	49,491,000	66,526,000	59,451,000	83,614,000	89,750,000	52,655,000	19,156,000	6,391,000	4,786,000	3,699,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	89,922,000	90,941,000	90,479,000	89,604,000	91,663,000	85,414,000	75,751,000	87,932,000	84,228,000	81,705,000	79,874,000	78,397,000	79,453,000	76,389,000	72,912,000	71,083,000	67,248,000	65,530,000	64,664,000	65,408,000	82,274,000	81,794,000	79,805,000	85,119,000	82,236,000	79,898,000	79,142,000	79,036,000	76,242,000	77,065,000	74,562,000	74,976,000	73,664,000	71,798,000	70,590,000	70,177,000	70,322,000	69,536,000	67,885,000	71,115,000	73,256,000	73,552,000	74,331,000	76,051,000	74,861,000	78,388,000	74,816,000	34,576,000	22,517,000	22,372,000	21,360,000	19,972,000	18,176,000	18,663,000	17,948,000	17,681,000	17,694,000	19,650,000	17,177,000	17,896,000	19,227,000	12,914,000	11,324,000	11,239,000	10,920,000	11,890,000	8,760,000	6,527,000	5,765,000									6,031,000	7,478,000	8,462,000	8,249,000
deferred income taxes	-24,621,000	-88,747,000	-24,238,000	-38,960,000	7,195,000	-6,680,000	-133,616,000	-173,987,000	-56,878,000	-13,550,000	-13,023,000	-146,029,000	-1,136,000	-2,462,000	-1,850,000	-92,293,000	0	77,508,000	-2,992,000	70,125,000	-12,401,000	20,797,000	-83,501,000	212,260,000	19,060,000	-271,478,000	43,204,000	35,069,000	27,619,000	34,615,000	7,633,000	-46,708,000	-4,908,000	8,176,000	-5,563,000	-2,694,000	1,739,000	3,320,000	3,186,000	-4,104,000	-816,000			-22,884,000	-27,934,000	-7,320,000	-12,017,000	39,356,000	3,723,000			-6,166,000	-733,000	-3,039,000	-783,000	12,482,000	19,913,000	12,929,000	10,110,000	-12,407,000	-4,652,000	-11,995,000	776,000	-10,790,000	8,334,000	-5,122,000	7,424,000	6,419,000	-4,936,000	17,935,000	-647,000	15,374,000	51,187,000	-13,413,000	21,954,000	29,624,000	7,417,000	2,669,000	876,000	-100,000	-3,214,000
equity-based compensation expense	76,854,000	69,901,000	67,211,000	68,495,000	73,911,000	73,084,000	71,110,000	69,588,000	68,543,000	62,834,000	58,099,000	56,321,000	55,746,000	52,109,000	55,988,000	53,153,000	47,414,000	45,725,000	42,905,000	44,845,000	53,240,000	38,806,000	50,343,000	47,214,000	41,095,000	42,124,000	41,783,000	43,802,000	35,323,000	32,255,000	38,595,000	39,288,000	34,716,000	32,570,000	35,774,000	39,734,000	32,948,000	30,632,000	32,040,000	33,085,000	24,334,000	23,046,000	23,235,000	25,241,000	25,648,000	24,027,000	24,414,000	29,174,000	16,417,000	18,224,000	17,744,000	14,788,000	12,456,000	12,759,000	13,009,000	13,958,000	13,358,000	10,227,000	14,049,000	15,408,000	11,629,000	10,272,000	9,813,000	10,802,000	11,766,000	10,873,000	6,664,000	6,251,000
other	10,210,000	4,182,000	-150,000	40,761,000	1,559,000	12,729,000	-2,751,000	33,574,000	-3,121,000	-66,514,000	-8,690,000	-23,535,000	-2,047,000	5,273,000	2,917,000	-10,822,000	7,811,000	-327,000	4,026,000	-5,055,000	-1,494,000	-1,343,000	2,191,000	10,933,000	17,866,000	-1,108,000	6,569,000	8,275,000	-4,738,000	-1,292,000	16,807,000	17,929,000	10,256,000	10,592,000	10,011,000	3,621,000	1,902,000	1,607,000	5,526,000	8,241,000	2,741,000	-2,428,000	4,115,000	4,550,000	6,115,000	16,317,000	8,406,000	7,206,000	1,367,000	881,000	1,423,000	477,000	746,000	-1,600,000	-1,964,000	1,159,000	2,535,000	953,000	3,200,000	2,665,000	2,074,000	-15,157,000	9,303,000	461,000	-237,000	1,597,000	-614,000	537,000	839,000	-1,517,000	-694,000	1,046,000	-448,000	547,000	-797,000	267,000	-973,000	-82,000	-347,000	1,151,000	918,000
changes in operating assets and liabilities	266,645,000	423,297,000	-69,537,000		738,102,000	-492,867,000	-246,785,000		-356,840,000	181,201,000	-838,480,000		-39,469,000	-657,318,000	-312,329,000		-157,187,000	-396,593,000	-112,020,000		260,951,000	-67,521,000	136,843,000		64,524,000	184,684,000	92,330,000		-292,607,000	-113,863,000	64,962,000		-95,776,000	-75,207,000	39,702,000		-131,142,000	-129,947,000	-109,092,000		13,986,000	-135,441,000	-150,388,000		-6,931,000	66,542,000	143,123,000		51,406,000	88,680,000	-34,215,000		25,259,000	-62,849,000	37,829,000
net cash from operating activities	1,384,836,000	1,453,840,000	951,163,000	1,122,725,000	1,726,438,000	1,140,187,000	1,189,588,000	443,934,000	757,710,000	1,440,506,000	457,524,000	1,435,935,000	1,165,080,000	344,637,000	642,511,000	813,048,000	541,428,000	307,928,000	464,047,000	880,487,000	932,821,000	642,419,000	720,286,000	718,358,000	1,050,379,000	28,704,000	858,306,000	729,272,000	422,688,000	404,098,000	473,224,000	423,824,000	182,911,000	294,545,000	448,997,000	292,066,000	191,037,000	161,239,000	141,161,000	245,891,000	290,210,000	129,023,000	51,925,000	174,988,000	102,457,000	193,226,000	249,262,000	96,715,000	146,397,000	169,016,000	86,900,000	198,108,000	241,593,000	185,583,000	255,744,000	2,704,000	-58,120,000	-24,152,000	-38,989,000	43,132,000	200,447,000	145,985,000	21,440,000	222,447,000	293,493,000	151,401,000	162,038,000	216,627,000	92,266,000	109,635,000	111,405,000	47,381,000	133,884,000	101,299,000			82,404,000	40,579,000
cash flows from investing activities:
capital expenditures and intangible assets	-103,654,000	-115,276,000	-76,992,000	-78,670,000	-119,457,000	-163,378,000	-140,063,000	-125,746,000	-145,368,000	-138,493,000	-136,427,000	-104,622,000	-89,596,000	-92,072,000	-62,806,000	-50,554,000	-51,375,000	-62,054,000	-39,256,000	-65,948,000	-75,522,000	-105,923,000	-56,098,000	-79,655,000	-49,057,000	-84,693,000	-60,064,000	-34,811,000	-44,116,000	-36,513,000	-41,979,000	-51,726,000	-46,007,000	-28,143,000	-49,454,000								-23,778,000	-43,140,000	-34,766,000	-38,924,000	-43,965,000	-36,880,000	-27,978,000	-26,682,000	-15,732,000	-34,571,000	-35,769,000	-38,025,000	-19,130,000	-5,832,000	-5,848,000	-10,866,000	-12,417,000	-15,151,000	-18,951,000	-19,291,000	-24,417,000	-14,144,000	-14,305,000	-18,777,000	-13,966,000	-12,920,000
business acquisitions, net of cash acquired				0	0
proceeds from maturities of available-for-sales securities	11,220,000	15,841,000	7,275,000		32,577,000	17,743,000	14,695,000
proceeds from sales of available-for-sale securities				0
net cash from investing activities	-92,360,000	-101,958,000	-74,683,000	-55,180,000	-84,332,000	-267,247,000	-127,803,000	-75,937,000	-94,564,000	186,083,000	596,693,000	689,061,000	115,936,000	69,940,000	-801,666,000	-430,209,000	169,772,000	-734,329,000	750,682,000	-623,483,000	-1,008,171,000	666,931,000	-672,331,000	1,261,280,000	2,085,864,000	-294,813,000	-303,891,000		-467,250,000	-2,027,217,000	376,752,000	521,514,000	135,731,000	14,395,000	-79,157,000	-340,456,000	-394,636,000	-378,875,000	7,871,000	-74,513,000	-95,810,000	-113,830,000	18,939,000	-60,710,000	-47,273,000	-70,197,000	-60,457,000	711,461,000	-310,200,000	-30,561,000	-100,974,000	-351,368,000	-47,258,000	-37,641,000	-43,646,000	-23,139,000	44,750,000	3,572,000	-15,591,000	-26,726,000	-40,747,000	-366,451,000	-58,478,000	-30,129,000											-50,257,000	-22,446,000
cash flows from financing activities:
principal payments on debt, including finance lease obligations	-1,060,000	-986,000	-253,109,000
treasury stock purchases	-980,561,000	-645,458,000	-843,238,000	-869,014,000	-581,943,000	-456,276,000	-109,779,000	-876,089,000	-1,338,006,000	-414,815,000	-1,236,753,000	-431,255,000	-1,094,571,000	-723,297,000	-448,581,000	-41,017,000	-245,433,000	-1,005,067,000	-78,132,000	-1,108,560,000	-934,637,000	-1,519,000	-1,735,895,000	-1,306,309,000	-80,105,000	-1,111,450,000	-155,385,000	-525,778,000	-216,372,000	-67,668,000	-1,854,000	-27,114,000	-20,092,000	-12,798,000	-98,385,000	-74,339,000	-124,943,000	-65,536,000	-308,422,000	-40,249,000	-52,415,000	-47,910,000	-104,285,000	-2,275,000	-243,297,000	-355,010,000	-355,079,000	-661,059,000	-18,909,000	-20,642,000	-72,053,000	-53,753,000	-8,617,000	-4,151,000	-144,795,000	-2,356,000	-3,197,000	-546,000	-24,448,000	-2,755,000	-3,590,000	-737,000	-761,000	-9,464,000	-768,400,000	-239,012,000	-75,285,000	-1,048,000	-37,002,000	-73,602,000	-61,917,000	-78,690,000	-99,288,000								0
dividends paid	-262,707,000	-264,414,000	-230,332,000	-232,335,000	-233,977,000	-235,980,000	-205,615,000	-208,056,000	-210,587,000	-211,216,000	-185,431,000	-185,385,000	-186,551,000	-187,927,000	-167,129,000	-167,739,000	-163,510,000	-166,721,000	-158,868,000	-164,873,000	-171,196,000	-167,907,000	-174,372,000	-82,005,000	-79,739,000	-73,127,000	-72,738,000	-73,709,000	-73,337,000	-48,397,000	-48,052,000	-47,308,000	-47,539,000	-47,896,000	-47,659,000	-28,714,000	-28,724,000	-29,381,000	-29,240,000
reissuance of treasury stock related to employee stock purchase plan	0				0				0				0				0				0				0				17,223,000	0	19,320,000				19,245,000
proceeds from issuance of common stock	8,235,000	1,704,000	2,818,000	3,438,000	0	877,000	6,796,000	997,000	492,000	3,451,000	742,000	851,000	9,626,000	8,108,000	5,538,000	1,869,000	1,714,000	632,000	3,869,000	1,694,000	5,010,000			2,626,000	2,517,000	3,073,000	1,042,000	369,000	7,964,000	3,121,000	1,459,000	1,547,000	308,000	1,173,000	377,000	1,285,000	7,403,000	4,223,000	4,609,000	8,657,000	5,111,000	8,449,000	12,574,000	16,713,000	15,132,000	6,583,000	951,000	0	301,000	1,311,000	164,000	2,179,000	5,980,000	3,407,000	835,000	2,256,000	6,287,000	1,283,000	1,294,000	3,150,000	2,588,000	0	3,398,000	6,708,000	12,175,000	5,892,000	22,662,000	1,739,000	43,698,000	61,602,000	61,926,000	12,174,000	23,456,000	48,923,000	30,986,000	10,939,000	9,290,000	6,658,000	31,068,000	17,136,000	8,523,000
net cash from financing activities	-1,235,793,000	-859,894,000	-1,326,012,000	-1,037,986,000	-819,528,000	-662,212,000	-310,941,000	-1,023,534,000	-1,549,708,000	-578,103,000	-1,427,592,000	-1,381,774,000	-1,288,406,000	-865,317,000	-631,485,000	563,400,000	225,462,000	-1,150,696,000	-262,096,000	-1,527,856,000	1,643,522,000	-515,553,000	-1,990,193,000	-2,160,769,000	-186,462,000	-396,022,000	-528,804,000	-539,809,000	-333,819,000	-1,729,258,000	-29,508,000	1,861,887,000	-57,160,000	-85,736,000	-123,246,000	-87,557,000	862,635,000	-90,769,000	-305,837,000	-11,373,000	-34,502,000	-40,215,000	-76,645,000	26,950,000	-221,330,000	-348,542,000	-344,868,000	-653,001,000	67,596,000	30,302,000	-137,644,000	699,994,000	14,724,000	-51,533,000	-136,199,000	4,398,000	8,687,000	-240,051,000	-39,451,000	9,985,000				25,647,000	-738,992,000	-258,679,000							-75,374,000	-18,870,000	30,986,000	10,939,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	-8,452,000	6,725,000	-11,031,000		-2,302,000	17,878,000	-16,925,000		-5,090,000	-4,678,000	-3,776,000		-5,756,000	8,187,000	4,082,000		-10,715,000	5,055,000	-4,193,000		4,128,000	-2,721,000	-2,311,000
net change in cash, cash equivalents, and restricted cash	48,231,000
cash, cash equivalents, and restricted cash at beginning of period	0	0	5,587,372,000		0	0	3,773,535,000		0	0	4,670,750,000		0	0	5,169,083,000		0	0	3,913,396,000		0	0	4,768,558,000
cash, cash equivalents, and restricted cash at end of period	48,231,000	498,713,000	5,126,809,000		820,276,000	228,606,000	4,507,454,000		-891,652,000	1,043,808,000	4,293,599,000		-13,146,000	-442,553,000	4,382,525,000		925,947,000	-1,572,042,000	4,861,836,000		1,572,300,000	791,076,000	2,824,009,000
schedule of non-cash transactions:
accrued payables for stock repurchases, including applicable excise tax	-400,000
accrued payables for capital expenditures	-18,004,000	24,458,000	38,668,000	-6,326,000	-56,269,000	15,321,000	79,173,000	22,366,000	-38,495,000	30,308,000	66,117,000	-18,823,000	7,933,000	34,549,000	37,733,000	8,122,000	1,724,000	-2,367,000	30,333,000	-4,098,000	-9,299,000	-31,000	36,613,000	-8,609,000	3,579,000	-5,500,000	34,531,000	7,208,000	-14,139,000	12,585,000	11,631,000
dividends payable	-1,670,000	-1,907,000	265,040,000	-1,776,000	-934,000	-2,003,000	235,980,000	-2,442,000	-2,530,000	-629,000	211,216,000	41,000	-1,221,000	-1,435,000	188,046,000	-611,000	4,230,000	-3,211,000	166,721,000	-6,006,000	-6,322,000	3,289,000	167,907,000	92,342,000	2,287,000	6,616,000	73,127,000	-1,215,000	615,000	24,941,000	48,397,000
transfers of finished goods inventory to property and equipment	17,363,000	19,913,000	18,014,000	11,924,000	8,000,000	36,134,000	20,798,000	12,952,000	6,794,000	39,804,000	15,518,000
reconciliation of cash, cash equivalents, and restricted cash
cash and cash equivalents	48,943,000	497,139,000	5,126,150,000	31,408,000	820,932,000	228,217,000	4,256,499,000	-672,718,000	-891,825,000	1,044,393,000	4,042,151,000	744,897,000	-13,799,000	-441,902,000	4,129,067,000	953,586,000	925,699,000	-1,571,295,000	4,607,182,000	-1,273,392,000	1,571,818,000	791,708,000	2,568,085,000
restricted cash and cash equivalents	-712,000	1,574,000	659,000	-372,000	-656,000	389,000	250,955,000	498,000	173,000	-585,000	251,448,000
total cash, cash equivalents, and restricted cash	48,231,000	498,713,000	5,126,809,000	31,036,000	820,276,000	228,606,000	4,507,454,000	-672,220,000	-891,652,000	1,043,808,000	4,293,599,000	743,924,000	-13,146,000	-442,553,000	4,382,525,000	953,342,000	925,947,000	-1,572,042,000	4,861,836,000	-1,273,989,000	1,572,300,000	791,076,000	2,824,009,000
net increase in cash, cash equivalents, and restricted cash			-460,563,000		820,276,000	228,606,000	733,919,000								-786,558,000				948,440,000				-1,944,549,000
accrued payables for stock repurchases			37,768,000		-26,044,000	30,037,000	88,000	-4,578,000	-15,479,000	19,977,000	126,000	14,150,000	-17,191,000	4,447,000	18,599,000	-213,000	6,000	276,000	13,000	-1,608,000	1,633,000	-158,000	162,000	-2,049,000			4,350,000		-6,110,000
changes in operating asset and liability accounts:
accounts receivable, net of allowance
inventories
prepaid expenses and other assets
trade accounts payable
deferred profit
accrued expenses and other liabilities
purchases of available-for-sale securities								0	-299,362,000	-243,160,000	-25,297,000	-146,647,000	-790,525,000	-702,028,000	-1,750,188,000	-1,007,804,000	-270,128,000	-1,472,063,000	-147,632,000	-954,361,000	-1,190,500,000	-35,359,000	-749,829,000	-155,370,000	-125,973,000	-826,079,000	-1,425,407,000	-987,791,000	-1,223,150,000	-2,332,761,000	-38,149,000	-30,184,000	-36,522,000	-449,438,000	-358,854,000	-929,956,000	-1,092,989,000	-726,763,000	-337,100,000	-488,312,000	-364,642,000	-302,881,000	-156,409,000	-265,043,000	-204,839,000	-405,887,000	-222,187,000	-244,792,000	-404,061,000	-76,526,000	-158,050,000	-431,823,000	-51,746,000	-29,958,000	-50,958,000	-29,638,000	-10,987,000	-54,644,000	-18,259,000	-125,408,000	-158,039,000	-51,169,000	-49,617,000	-52,048,000	-6,170,000	-413,094,000	-319,609,000	-319,208,000	-89,133,000	-11,616,000	-17,829,000	-10,886,000	-67,575,000	-45,925,000	-68,906,000	-64,986,000	-45,001,000	-107,690,000	38,769,000	-349,554,000	-310,729,000
proceeds from maturities of available-for-sale securities
principal payments on long-term debt and finance lease obligations and payments for debt issuance costs
effect of exchange rate changes on cash, cash equivalents and restricted cash
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
schedule of non-cash transactions
supplemental disclosures:
cash payments for interest
cash payments for income taxes
principal payments on debt					-2,209,000	-17,082,000	-1,854,000		-1,821,000	-1,698,000	-6,338,000		-16,245,000	-4,596,000	-19,173,000		-617,637,000	-17,987,000	-28,965,000		-30,225,000	-6,440,000	-79,831,000
repayment of borrowings on revolving credit facility
maturities of available-for-sales securities									33,027,000	27,260,000	106,836,000		662,031,000	691,754,000	597,252,000		211,228,000	351,980,000	600,347,000
sales of available-for-sale securities									345,519,000	541,071,000	656,504,000		362,023,000	178,376,000	415,862,000		270,059,000	457,796,000	337,763,000																																																											240,139,000	-59,058,000	250,375,000
net decrease in cash, cash equivalents, and restricted cash											-377,151,000
net (repayment) from commercial paper
impairment of investments
net (repayment) proceeds from commercial paper
excess tax benefits on equity-based compensation plans
(gains) losses on extinguishment of debt
gain on sale of assets
income tax benefit (expense) on equity-based compensation plans
excess tax (benefits) expense on equity-based compensation plans
excess tax benefits (expense) on equity-based compensation plans
cash and cash equivalents at end of year
net proceeds from commercial paper
impairment of long-lived assets
net cash (used by) provided by investing activities
schedule of noncash transactions:
schedule of noncash transactions
excess tax (benefit) expense on equity-based compensation plans
gain on sale of real estate
issuance (repayment) of notes receivable
purchases of other investments
(uses of) transfer to restricted cash and investments
proceeds from issuance of long-term debt, net issuance costs
cash acquired in (paid for) business acquisition
purchase of equity method and other investments
net cash received in settlement of stock repurchase contracts
net proceeds from issuance of long-term debt & convertible notes
proceeds from sale of warrants
purchase of convertible note hedge
net cash received in settlement of (paid in advance for) stock repurchase contracts
income tax impact on equity-based compensation plans
excess tax impact on equity-based compensation plans
receipt of loan payment
cash acquired in business acquisition
loss on equity method investment
acquisitions of business, net of cash acquired
loans made
adjustments to reconcile net income to net cash from by operating activities:
changes in operating asset accounts:
adjustments to reconcile net income to net cash provided (used for) by operating activities:
sales of other investments
acquisitions of businesses
changes in working capital accounts:
schedule of noncash transactions acquisition of leased equipment
asset impairment charge
loss on disposal of long-lived assets
net noncash gain on retirement of 4% notes
proceeds from settlement of swap
income tax benefit from stock option exercises
payments on capital lease
tax benefit from employee stock options
transfer of restricted cash
change in other working capital accounts
net cash (used for)/provided by investing activities
adjustments to reconcile net income to net cash provided by/(used for) operating activities:
patent settlement
sales of accounts receivable
transfer of restricted cash upon settlement of swap
cumulative effect of change in accounting principle, eitf 00-19
cumulative effect of change in accounting principle, sab 101 net of tax
purchased technology for research and development
strategic investments
net proceeds from issuance of debt
gain on equity derivative contracts in company stock
amortization of deferred compensation